06/08/2026 Biogen completed the acquisition of RayThera to strengthen its immunology pipeline Ono Pharmaceutical entered into a drug discovery partnership with Mediar Therapeutics to create novel antibody therapeutics for fibro-inflammatory diseases Mediar Therapeutics entered into a collaboration and option agreement with Ono Pharmaceutical Biogen completed the acquisition of RayThera to strengthen its immunology pipeline (Ref) Biogen announced the completion of its acquisit

01/05/2026 UCB announced acquisition of IMIDomics’ patient insight business, strengthening capabilities in IMIDs UCB announced acquisition of IMIDomics’ patient insight business, strengthening capabilities in IMIDs (Ref) UCB and IMIDomics announced that UCB had acquired the Patients Insights Business of IMIDomics, gaining access to multi-omic datasets for immune mediated inflammatory diseases (IMIDs). The Patient Insight Business enhanced UCB’s ability to identify novel drug